Abstract
MOLECULAR adsorbent recirculating system (MARS) is a new treatment for liver failure based on the same principle as hemodialysis. However, the blood is dialyzed against an albumin-enriched dialyzate to facilitate the removal of albumin-bound toxins as well as bilirubin, aromatic amino acids and water-soluble substances. This method, which has been introduced clinically in recent years, is best used in patients with acute decompensation of chronic liver disease, but there are also some reports in patients with acute liver failure (ALF). We decided to use MARS in patients with ALF who also were considered to need a liver transplant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.